台灣臨床試驗主持人資料庫|TPIDB

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberADCT-402-107

Active

2023-01-23 - 2027-10-13

Phase I

Recruiting2

ICD-10C83.38

Diffuse large B-cell lymphoma, lymph nodes of multiple sites

ICD-10C84.68

Anaplastic large cell lymphoma, ALK-positive, lymph nodes of multiple sites

ICD-10C84.78

Anaplastic large cell lymphoma, ALK-negative, lymph nodes of multiple sites

ICD-10C85.20

Mediastinal (thymic) large B-cell lymphoma, unspecified site

ICD-10C85.21

Mediastinal (thymic) large B-cell lymphoma, lymph nodes of head, face, and neck

ICD-10C85.22

Mediastinal (thymic) large B-cell lymphoma, intrathoracic lymph nodes

ICD-10C85.23

Mediastinal (thymic) large B-cell lymphoma, intra-abdominal lymph nodes

ICD-10C85.24

Mediastinal (thymic) large B-cell lymphoma, lymph nodes of axilla and upper limb

ICD-10C85.25

Mediastinal (thymic) large B-cell lymphoma, lymph nodes of inguinal region and lower limb

ICD-10C85.26

Mediastinal (thymic) large B-cell lymphoma, intrapelvic lymph nodes

ICD-10C85.27

Mediastinal (thymic) large B-cell lymphoma, spleen

ICD-10C85.28

Mediastinal (thymic) large B-cell lymphoma, lymph nodes of multiple sites

ICD-10C85.29

Mediastinal (thymic) large B-cell lymphoma, extranodal and solid organ sites

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9200.08

Reticulosarcoma, lymph nodes of multiple sites

Trial Applicant

Pharmaceutical Research Associates Taiwan Inc.
Sponsor
Trial scale

Multi-Regional Multi-Center
Update

2026/06/01

Investigators and Locations

Principal Investigator 譚傳德無

Koo Foundation Sun Yat-Sen Cancer Center

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Chieh-Lung Cheng Division of Hematology & Oncology

National Taiwan University Hospital

Co-Principal Investigator

Chien-Chin Lin Division of Hematology & Oncology
- - Division of Hematology & Oncology
Huai-Hsuan Huang Division of General Internal Medicine
Wen-Chien Chou Division of Hematology & Oncology
柯紀綸 Division of Radiology
Tai-Chung Huang Division of Hematology & Oncology
田豐銘 Division of Hematology & Oncology
MING YAO Division of Hematology & Oncology
Chien-Yuan Chen Division of General Internal Medicine
HSIN-AN HOU Division of Hematology & Oncology
BANG-BIN CHEN Division of Radiology
CHENG-HONG TSAI Division of Hematology & Oncology

Clinical Trials List

Investigators and Locations

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants